Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
Primary tumors are often heterogeneous, composed of therapy-sensitive and emerging therapy-resistant cancer cells. Interestingly, treatment of therapy-sensitive tumors in heterogeneous tumor microenvironments results in apoptosis of therapy-resistant tumors. In this study, we identify a prostate apoptosis response-4 (Par-4) amino-terminal fragment (PAF) that is released by diverse therapy-sensitive cancer cells following therapy-induced caspase cleavage of the tumor suppressor Par-4 protein. PAF caused apoptosis in cancer cells resistant to therapy and inhibited tumor growth. A VASA segment of Par-4 mediated its binding and degradation by the ubiquitin ligase Fbxo45, resulting in loss of Par-4 proapoptotic function. Conversely, PAF, which contains this VASA segment, competitively bound to Fbxo45 and rescued Par-4–mediated induction of cancer cell–specific apoptosis. Collectively, our findings identify a molecular decoy naturally generated during apoptosis that inhibits a ubiquitin ligase to overcome therapy resistance in tumors.
Document Type
Article
Publication Date
8-2017
Digital Object Identifier (DOI)
https://doi.org/10.1158/0008-5472.CAN-16-1970
Funding Information
V.M. Rangnekar was recipient of NIH grants R01CA187273, R01CA165469, and R21CA179283.
Related Content
Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/).
Repository Citation
Hebbar, Nikhil; Burikhanov, Ravshan; Shukla, Nidhi; Qiu, Shirley; Zhao, Yanming; Elenitoba-Johnson, Kojo S. J.; and Rangnekar, Vivek M., "A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors" (2017). Radiation Medicine Faculty Publications. 18.
https://uknowledge.uky.edu/radmed_facpub/18
Supplementary Data
Notes/Citation Information
Published in Cancer Research, v. 77, issue 15, p. 4039-4050.
© 2017 American Association for Cancer Research
The copyright holder has granted the permission for posting the article here.
The document available for download is the authors' post-peer-review final draft of the article.